微管蛋白抑制剂治疗乳腺癌行业内核心竞争企业包括Bristol-Myers Squibb, Beijing Union, Jiangsu Aosaikang Pharma, Chuntch, Celgene Corporation, CSPC Pharmaceutical, Otsuka Pharmaceutical, Hospira, Aosaikang Pharm, Taj Accura, ...